- Home
- ALRS vs AUTL Comparison
ALRS vs AUTL Comparison
Compare ALRS & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALRS
- AUTL
- Stock Information
- Founded
- ALRS 1879
- AUTL 2014
- Country
- ALRS United States
- AUTL United Kingdom
- Employees
- ALRS N/A
- AUTL N/A
- Industry
- ALRS Major Banks
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALRS Finance
- AUTL Health Care
- Exchange
- ALRS Nasdaq
- AUTL Nasdaq
- Market Cap
- ALRS 548.4M
- AUTL 625.4M
- IPO Year
- ALRS 2019
- AUTL 2018
- Fundamental
- Price
- ALRS $22.58
- AUTL $1.46
- Analyst Decision
- ALRS Hold
- AUTL Strong Buy
- Analyst Count
- ALRS 5
- AUTL 5
- Target Price
- ALRS $25.30
- AUTL $9.12
- AVG Volume (30 Days)
- ALRS 79.8K
- AUTL 3.8M
- Earning Date
- ALRS 10-28-2025
- AUTL 08-12-2025
- Dividend Yield
- ALRS 3.72%
- AUTL N/A
- EPS Growth
- ALRS 350.15
- AUTL N/A
- EPS
- ALRS 1.59
- AUTL N/A
- Revenue
- ALRS $252,130,000.00
- AUTL $29,934,000.00
- Revenue This Year
- ALRS $42.87
- AUTL $634.25
- Revenue Next Year
- ALRS $2.77
- AUTL $93.16
- P/E Ratio
- ALRS $14.18
- AUTL N/A
- Revenue Growth
- ALRS 53.68
- AUTL 185.17
- 52 Week Low
- ALRS $15.78
- AUTL $1.11
- 52 Week High
- ALRS $24.41
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- ALRS 57.40
- AUTL 27.33
- Support Level
- ALRS $22.03
- AUTL $1.39
- Resistance Level
- ALRS $22.65
- AUTL $1.55
- Average True Range (ATR)
- ALRS 0.49
- AUTL 0.10
- MACD
- ALRS 0.09
- AUTL -0.02
- Stochastic Oscillator
- ALRS 77.72
- AUTL 14.00
About ALRS Alerus Financial Corporation
Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and Mortgage. It provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services as well as wealth management services, including financial & estate planning, trust, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.